Patent granted for MS drug Tecfidera (BG-12) until 2028

Discuss Tecfidera (BG-12, dimethyl fumarate) as an oral treatment for multiple sclerosis.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Patent granted for MS drug Tecfidera (BG-12) until 2028

Post by MSUK »

Patent granted for Multiple Sclerosis drug Tecfidera (BG-12) until 2028

Biogen Idec Inc announces it has been granted a new patent that will help protect the market exclusivity of its multiple sclerosis drug Tecfidera (BG-12) until 2028.

The new patent covers the dosing regimen for Tecfidera of 480 milligrams a day....Read more - http://www.ms-uk.org/index.cfm/BG12
MS-UK - http://www.ms-uk.org/
Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “Tecfidera (BG-12, Dimethyl fumarate)”